Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma von Mai, E K, Bertsch, U, Dürig, J, Kunz, C, Haenel, M, Blau, I W, Munder, M, Jauch, A, Schurich, B, Hielscher, T, Merz, M, Huegle-Doerr, B, Seckinger, A, Hose, D, Hillengass, J, Raab, M S, Neben, K, Lindemann, H-W, Zeis, M, Gerecke, C, Schmidt-Wolf, I G H, Weisel, K, Scheid, C, Salwender, H, Goldschmidt, H

Volltext

Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma: an interim analysis from the prospective GMMG-MM5 trial von Merz, Maximilian, Salwender, Hans, Haenel, Mathias, Mai, Elias K, Bertsch, Uta, Kunz, Christina, Hielscher, Thomas, Blau, Igor W, Scheid, Christof, Hose, Dirk, Seckinger, Anja, Jauch, Anna, Hillengass, Jens, Raab, Marc S, Schurich, Baerbel, Munder, Markus, Schmidt-Wolf, Ingo G H, Gerecke, Christian, Lindemann, Hans-Walter, Zeis, Matthias, Weisel, Katja, Duerig, Jan, Goldschmidt, Hartmut

Volltext

The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia von Nückel, H, Switala, M, Sellmann, L, Horn, P A, Dürig, J, Dührsen, U, Küppers, R, Grosse-Wilde, H, Rebmann, V

Volltext

Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important... von DÜRIG, J, BUG, S, KLEIN-HITPASS, L, BOES, T, JÖNS, T, MARTIN-SUBERO, J. I, HARDER, L, BAUDIS, M, DÜHRSEN, U, SIEBERT, R

Volltext

Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status von HÜTTMANN, A, KLEIN-HITPASS, L, DÜHRSEN, U, DÜRIG, J, THOMALE, J, DEENEN, R, CARPINTEIRO, A, NÜCKEL, H, EBELING, P, FÜHRER, A, EDELMANN, J, SELLMANN, L

Volltext

Percentage of smudge cells determined on routine blood smears is a novel prognostic factor in chronic lymphocytic leukemia von Johansson, P, Eisele, L, Klein-Hitpass, L, Sellmann, L, Dührsen, U, Dürig, J, Nückel, H

Volltext

Short telomeres and high telomerase activity in T-cell prolymphocytic leukemia von ROTH, A, DÜRIG, J, HIMMELREICH, H, BUG, S, SIEBERT, R, DÜHRSEN, U, LANSDORP, P. M, BAERLOCHER, G. M

Volltext

Richter transformation in chronic lymphocytic leukemia (CLL)—a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials von Al-Sawaf, O., Robrecht, S., Bahlo, J., Fink, A. M., Cramer, P., v Tresckow, J., Lange, E., Kiehl, M., Dreyling, M., Ritgen, M., Dürig, J., Tausch, E., Schneider, C., Stilgenbauer, S., Wendtner, C. M., Fischer, K., Goede, Hallek, M., Eichhorst, B.

Volltext

Noncanonical effector functions of the T-memory–like T-PLL cell are shaped by cooperative TCL1A and TCR signaling von Oberbeck, S., Schrader, A., Warner, K., Jungherz, D., Crispatzu, G., von Jan, J., Chmielewski, M., Ianevski, A., Diebner, H.H., Mayer, P., Kondo Ados, A., Wahnschaffe, L., Braun, T., Müller, T.A., Wagle, P., Bouska, A., Neumann, T., Pützer, S., Varghese, L., Pflug, N., Thelen, M., Makalowski, J., Riet, N., Göx, H.J.M., Rappl, G., Altmüller, J., Kotrová, M., Persigehl, T., Hopfinger, G., Hansmann, M.L., Schlößer, H., Stilgenbauer, S., Dürig, J., Mougiakakos, D., von Bergwelt-Baildon, M., Roeder, I., Hartmann, S., Hallek, M., Moriggl, R., Brüggemann, M., Aittokallio, T., Iqbal, J., Newrzela, S., Abken, H., Herling, M.

Volltext

Human multipotent hematopoietic progenitor cell expansion is neither supported in endothelial and endothelial/mesenchymal co-cultures nor in NSG mice von Radtke, Stefan, Görgens, André, da Conceição Castro, Symone Vitoriano, Kordelas, Lambros, Köninger, Angela, Dürig, Jan, Möllmann, Michael, Horn, Peter A., Giebel, Bernd

Volltext

Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial von Merz, Maximilian, Salwender, Hans, Haenel, Mathias, Mai, Elias K, Bertsch, Uta, Kunz, Christina, Hielscher, Thomas, Blau, Igor W, Scheid, Christof, Hose, Dirk, Seckinger, Anja, Jauch, Anna, Hillengass, Jens, Raab, Marc S, Schurich, Baerbel, Munder, Markus, Brossart, Peter, Gerecke, Christian, Lindemann, Hans-Walter, Zeis, Matthias, Weisel, Katja, Duerig, Jan, Goldschmidt, Hartmut

Volltext

Circulating tumor cells as a biomarker for response to therapy in multiple myeloma patients treated within the GMMG-MM5 trial von Huhn, S, Weinhold, N, Nickel, J, Pritsch, M, Hielscher, T, Hummel, M, Bertsch, U, Huegle-Doerr, B, Vogel, M, Angermund, R, Hänel, M, Salwender, H J, Weisel, K, Dürig, J, Görner, M, Kirchner, H, Peter, N, Graeven, U, Lordick, F, Hoffmann, M, Reimer, P, Blau, I W, Jauch, A, Dembowsky, K, Möhler, T, Wuchter, P, Goldschmidt, H

Volltext

Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia von Schroers, R, Griesinger, F, Trümper, L, Haase, D, Kulle, B, Klein-Hitpass, L, Sellmann, L, Dührsen, U, Dürig, J

Volltext

ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia von DÜRIG, J, NÜCKEL, H, CREMER, M, FÜHRER, A, HALFMEYER, K, FANDREY, J, MÖRÖY, T, KLEIN-HITPASS, L, DÜHRSEN, U

Volltext

The novel antisense Bcl-2 inhibitor SPC2996 causes rapid leukemic cell clearance and immune activation in chronic lymphocytic leukemia von Dürig, J, Dührsen, U, Klein-Hitpass, L, Worm, J, Hansen, J B Rode, Ørum, H, Wissenbach, M

Volltext

Deorphanization and characterization of the ectopically expressed olfactory receptor OR51B5 in myelogenous leukemia cells von Manteniotis, S, Wojcik, S, Göthert, J R, Dürig, J, Dührsen, U, Gisselmann, G, Hatt, H

Volltext

CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia von DÜRIG, J, NASCHAR, M, SCHMÜCKER, U, RENZING-KÖHLER, K, HÖLTER, T, HÜTTMANN, A, DÜHRSEN, U

Volltext

Bone marrow fibroblasts induce expression of PI3K/NF-κB pathway genes and a pro-angiogenic phenotype in CLL cells von Edelmann, J, Klein-Hitpass, L, Carpinteiro, A, Führer, A, Sellmann, L, Stilgenbauer, S, Dührsen, U, Dürig, J

Volltext

Differential expression of chemokine receptors in B cell malignancies von Duhrsen, U, Durig, J, Schmucker, U

Volltext

Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia: data from the prospective, multicenter phase-II CLL-009 trial von Bühler, A, Wendtner, C-M, Kipps, T J, Rassenti, L, Fraser, G A M, Michallet, A-S, Hillmen, P, Dürig, J, Gregory, S A, Kalaycio, M, Aurran-Schleinitz, T, Trentin, L, Gribben, J G, Chanan-Khan, A, Purse, B, Zhang, J, De Bedout, S, Mei, J, Hallek, M, Stilgenbauer, S

Volltext